Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Language
Publication year range
3.
Rev. esp. geriatr. gerontol. (Ed. impr.) ; 47(1): 33-37, ene.-feb. 2012.
Article in Spanish | IBECS | ID: ibc-96520

ABSTRACT

La enfermedad pulmonar obstructiva crónica (EPOC) es una de las enfermedades más comunes, su prevalencia aumenta con la edad, y comporta una alta morbilidad y mortalidad en la población anciana. En la actualidad, la EPOC se considera una enfermedad inflamatoria caracterizada por una obstrucción pulmonar que no es completamente reversible y que se asocia con una elevada comorbilidad. El tratamiento en los ancianos no difiere mucho del utilizado en adultos jóvenes, aunque la elevada comorbilidad, la polifarmacia y el uso de diferentes dispositivos de inhalación requieren que el tratamiento se adapte a cada paciente. La presencia de exacerbaciones, la inactividad y la inflamación sistémica junto con la disnea causa una disminución en la actividad física y pérdida de la funcionalidad. En esta revisión vamos a actualizar la fisiología, el diagnóstico y tratamiento de la EPOC en los ancianos y la prevención de los síndromes geriátricos en esta enfermedad(AU)


Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases. Its prevalence increases with the age, and causes a high morbidity and mortality in the elderly population. COPD is currently considered as an inflammatory disease characterised by a pulmonary obstruction that is not fully reversible, and is associated with a high comorbidity. The treatment in the elderly does not differ much from that used in young adults, although the high comorbidity, the multiple prescription drugs and the use of different inhalation devices means that treatment has to be adapted to each patient. The presence of exacerbations, inactivity, systemic inflammation and dyspnea leads to a decrease in activity and loss of physical function. In this review we will update the physiology, diagnosis and treatment of COPD in the elderly, and the prevention of geriatric syndromes in this disease(AU)


Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/prevention & control , Aging/pathology , Aging/physiology , Comorbidity , Recurrence/prevention & control , Pulmonary Disease, Chronic Obstructive/therapy , Indicators of Morbidity and Mortality
4.
Rev Esp Geriatr Gerontol ; 47(1): 33-7, 2012.
Article in Spanish | MEDLINE | ID: mdl-22172571

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases. Its prevalence increases with the age, and causes a high morbidity and mortality in the elderly population. COPD is currently considered as an inflammatory disease characterised by a pulmonary obstruction that is not fully reversible, and is associated with a high comorbidity. The treatment in the elderly does not differ much from that used in young adults, although the high comorbidity, the multiple prescription drugs and the use of different inhalation devices means that treatment has to be adapted to each patient. The presence of exacerbations, inactivity, systemic inflammation and dyspnea leads to a decrease in activity and loss of physical function. In this review we will update the physiology, diagnosis and treatment of COPD in the elderly, and the prevention of geriatric syndromes in this disease.


Subject(s)
Pulmonary Disease, Chronic Obstructive , Aged , Humans , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...